AL-MAGHRABI, J. A. Loss of expression of Syndecan-1 is associated with Tumor Recurrence, Metastatic Potential, and Poor Survival in patients with Colorectal carcinoma. Pakistan Journal of Medical Sciences, v. 37, n. 1, 8 Dec. 2020.